Orally Induced Hyperthyroidism Regulates Hypothalamic AMP-Activated Protein Kinase

Besides their direct effects on peripheral metabolic tissues, thyroid hormones (TH) act on the hypothalamus to modulate energy homeostasis. However, since most of the hypothalamic actions of TH have been addressed in studies with direct central administration, the estimation of the relative contribu...

Full description

Bibliographic Details
Main Authors: Valentina Capelli, Carmen Grijota-Martínez, Nathalia R. V. Dragano, Eval Rial-Pensado, Johan Fernø, Rubén Nogueiras, Jens Mittag, Carlos Diéguez, Miguel López
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/13/12/4204
_version_ 1797501874285314048
author Valentina Capelli
Carmen Grijota-Martínez
Nathalia R. V. Dragano
Eval Rial-Pensado
Johan Fernø
Rubén Nogueiras
Jens Mittag
Carlos Diéguez
Miguel López
author_facet Valentina Capelli
Carmen Grijota-Martínez
Nathalia R. V. Dragano
Eval Rial-Pensado
Johan Fernø
Rubén Nogueiras
Jens Mittag
Carlos Diéguez
Miguel López
author_sort Valentina Capelli
collection DOAJ
description Besides their direct effects on peripheral metabolic tissues, thyroid hormones (TH) act on the hypothalamus to modulate energy homeostasis. However, since most of the hypothalamic actions of TH have been addressed in studies with direct central administration, the estimation of the relative contribution of the central vs. peripheral effects in physiologic conditions of peripheral release (or administration) of TH remains unclear. In this study we used two different models of peripherally induced hyperthyroidism (i.e., T4 and T3 oral administration) to assess and compare the serum and hypothalamic TH status and relate them to the metabolic effects of the treatment. Peripheral TH treatment affected feeding behavior, overall growth, core body temperature, body composition, brown adipose tissue (BAT) morphology and uncoupling protein 1 (UCP1) levels and metabolic activity, white adipose tissue (WAT) browning and liver metabolism. This resulted in an increased overall uncoupling capacity and a shift of the lipid metabolism from WAT accumulation to BAT fueling. Both peripheral treatment protocols induced significant changes in TH concentrations within the hypothalamus, with T3 eliciting a downregulation of hypothalamic AMP-activated protein kinase (AMPK), supporting the existence of a central action of peripheral TH. Altogether, these data suggest that peripherally administered TH modulate energy balance by various mechanisms; they also provide a unifying vision of the centrally mediated and the direct local metabolic effect of TH in the context of hyperthyroidism.
first_indexed 2024-03-10T03:25:52Z
format Article
id doaj.art-ebc1e718f1224c7393b42b40cf6fe603
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-10T03:25:52Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-ebc1e718f1224c7393b42b40cf6fe6032023-11-23T09:54:26ZengMDPI AGNutrients2072-66432021-11-011312420410.3390/nu13124204Orally Induced Hyperthyroidism Regulates Hypothalamic AMP-Activated Protein KinaseValentina Capelli0Carmen Grijota-Martínez1Nathalia R. V. Dragano2Eval Rial-Pensado3Johan Fernø4Rubén Nogueiras5Jens Mittag6Carlos Diéguez7Miguel López8Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, 15782 Santiago de Compostela, SpainDepartment of Cell Biology, Faculty of Biology, Complutense University, 28040 Madrid, SpainDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, 15782 Santiago de Compostela, SpainDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, 15782 Santiago de Compostela, SpainHormone Laboratory, Haukeland University Hospital, N-5021 Bergen, NorwayDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, 15782 Santiago de Compostela, SpainInstitute for Endocrinology and Diabetes—Molecular Endocrinology, Center of Brain Behavior and Metabolism CBBM, University of Lübeck, 23562 Lübeck, GermanyDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, 15782 Santiago de Compostela, SpainDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, 15782 Santiago de Compostela, SpainBesides their direct effects on peripheral metabolic tissues, thyroid hormones (TH) act on the hypothalamus to modulate energy homeostasis. However, since most of the hypothalamic actions of TH have been addressed in studies with direct central administration, the estimation of the relative contribution of the central vs. peripheral effects in physiologic conditions of peripheral release (or administration) of TH remains unclear. In this study we used two different models of peripherally induced hyperthyroidism (i.e., T4 and T3 oral administration) to assess and compare the serum and hypothalamic TH status and relate them to the metabolic effects of the treatment. Peripheral TH treatment affected feeding behavior, overall growth, core body temperature, body composition, brown adipose tissue (BAT) morphology and uncoupling protein 1 (UCP1) levels and metabolic activity, white adipose tissue (WAT) browning and liver metabolism. This resulted in an increased overall uncoupling capacity and a shift of the lipid metabolism from WAT accumulation to BAT fueling. Both peripheral treatment protocols induced significant changes in TH concentrations within the hypothalamus, with T3 eliciting a downregulation of hypothalamic AMP-activated protein kinase (AMPK), supporting the existence of a central action of peripheral TH. Altogether, these data suggest that peripherally administered TH modulate energy balance by various mechanisms; they also provide a unifying vision of the centrally mediated and the direct local metabolic effect of TH in the context of hyperthyroidism.https://www.mdpi.com/2072-6643/13/12/4204thyroid hormonesAMPKhypothalamusbrown adipose tissuebrowning
spellingShingle Valentina Capelli
Carmen Grijota-Martínez
Nathalia R. V. Dragano
Eval Rial-Pensado
Johan Fernø
Rubén Nogueiras
Jens Mittag
Carlos Diéguez
Miguel López
Orally Induced Hyperthyroidism Regulates Hypothalamic AMP-Activated Protein Kinase
Nutrients
thyroid hormones
AMPK
hypothalamus
brown adipose tissue
browning
title Orally Induced Hyperthyroidism Regulates Hypothalamic AMP-Activated Protein Kinase
title_full Orally Induced Hyperthyroidism Regulates Hypothalamic AMP-Activated Protein Kinase
title_fullStr Orally Induced Hyperthyroidism Regulates Hypothalamic AMP-Activated Protein Kinase
title_full_unstemmed Orally Induced Hyperthyroidism Regulates Hypothalamic AMP-Activated Protein Kinase
title_short Orally Induced Hyperthyroidism Regulates Hypothalamic AMP-Activated Protein Kinase
title_sort orally induced hyperthyroidism regulates hypothalamic amp activated protein kinase
topic thyroid hormones
AMPK
hypothalamus
brown adipose tissue
browning
url https://www.mdpi.com/2072-6643/13/12/4204
work_keys_str_mv AT valentinacapelli orallyinducedhyperthyroidismregulateshypothalamicampactivatedproteinkinase
AT carmengrijotamartinez orallyinducedhyperthyroidismregulateshypothalamicampactivatedproteinkinase
AT nathaliarvdragano orallyinducedhyperthyroidismregulateshypothalamicampactivatedproteinkinase
AT evalrialpensado orallyinducedhyperthyroidismregulateshypothalamicampactivatedproteinkinase
AT johanfernø orallyinducedhyperthyroidismregulateshypothalamicampactivatedproteinkinase
AT rubennogueiras orallyinducedhyperthyroidismregulateshypothalamicampactivatedproteinkinase
AT jensmittag orallyinducedhyperthyroidismregulateshypothalamicampactivatedproteinkinase
AT carlosdieguez orallyinducedhyperthyroidismregulateshypothalamicampactivatedproteinkinase
AT miguellopez orallyinducedhyperthyroidismregulateshypothalamicampactivatedproteinkinase